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Identification of a Human Heme Exporter
that Is Essential for Erythropoiesis
through a balance among heme biosynthesis, utilization
for hemoproteins, and catabolism by the microsomal
enzyme, heme oxygenase (HO) (Ponka, 1997), to gener-
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Red cells have a unique requirement for heme as theand Janis L. Abkowitz1,*
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tent. Thus, coordinate regulation of heme and globinUniversity of Washington
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it has been shown that intracellular heme regulates both
the transcription and translation of globin mRNAs
through interference with the DNA binding of Bach1, aSummary
transcriptional repressor of the globin genes, and inhibi-
tion of an erythroid-specific eIF-2 kinase (Ogawa et al.,FLVCR, a member of the major facilitator superfamily
2001; Rafie-Kolpin et al., 2000). Thus, it appears thatof transporter proteins, is the cell surface receptor for
increasing intracellular heme levels during early erythro-feline leukemia virus, subgroup C. Retroviral interfer-
poiesis triggers the onset of globin protein synthesis,ence with FLVCR display results in a loss of erythroid
which ultimately reduces the levels of uncommittedprogenitors (colony-forming units-erythroid, CFU-E)
heme. The response of nonerythroid cells to any excessand severe anemia in cats. In this report, we demon-
in intracellular heme includes the rapid induction of HO.strate that human FLVCR exports cytoplasmic heme
However, as heme availability is critical for the continued
and hypothesize that human FLVCR is required on
development of erythroid progenitors, induction of this
developing erythroid cells to protect them from heme enzyme in erythroid cells may be inappropriate given its
toxicity. Inhibition of FLVCR in K562 cells decreases prolonged half-life (20 hr; Ibrahim et al., 1982), sug-
heme export, impairs their erythroid maturation and gesting a stage-specific requirement for a more dynamic
leads to apoptosis. FLVCR is upregulated on CFU-E, protection mechanism.
indicating that heme export is important in primary Previously, we and others cloned FLVCR (Quigley et
cells at this stage. Studies of FLVCR expression in al., 2000; Tailor et al., 1999), a cell surface protein that
cell lines suggest this exporter also impacts heme serves as the receptor for feline leukemia virus, sub-
trafficking in intestine and liver. To our knowledge, group C (FeLV-C). By homology, FLVCR is a member of
this is the first description of a mammalian heme trans- the major facilitator superfamily (MFS; Pao et al., 1994)
porter. of secondary permeases, which transport small solutes
(e.g., sugars, amino acids) across membranes in re-
Introduction sponse to chemico-osmotic gradients. However, the
transport function of this viral receptor was unknown.
Cats viremic with FeLV-C, a simple (nononcogene-Heme, a complex of iron and protoporphyrin IX, is an
containing) retrovirus, develop profound anemia (Ab-important component of a diverse group of hemopro-
kowitz et al., 1987; Onions et al., 1982; Riedel et al., 1986,teins, including those involved in oxygen transport and
1988; Wardrop et al., 1986); while BFU-E are presentstorage (hemoglobin, myoglobin), electron transfer and
at normal frequency, there is a paucity of CFU-E anddrug metabolism (cytochromes), and signal transduc-
erythroid precursors, suggesting that erythropoiesis istion (nitric oxide synthases) (Ponka, 1997). Heme, how-
arrested at the CFU-E/proerythroblast stage (Abkowitzever, is toxic, promoting oxidative cell membrane dam-
et al., 1987). Studies indicate that in infected cells, theage through lipid peroxidation, which necessitates tight
FeLV-C envelope surface unit protein acts as a domi-regulation of heme’s intracellular concentration (Ryter
nant-negative protein to prevent the display and/or func-and Tyrrell, 2000). This regulation is thought to occur
tion of its cell surface receptor (feFLVCR) and cause this
phenotype (Weiss and Tailor, 1995; Riedel et al., 1988;
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few as 11 amino acids of FeLV-A envelope variable re-
gion 1 (VR1) with amino acids contained in the VR1 of
FeLV-C alters both the host range and receptor use of
FeLV-A to that of FeLV-C and results in anemia in viremic
cats (Rigby et al., 1992). Thus, the genetic determinants
of viral binding to feFLVCR and the impairment of ery-
throid differentiation map to VR1 of the FeLV-C enve-
lope. Since feFLVCR expression is downregulated by
intracellular envelope production in all infected BM cells
(including BFU-E and CFU-GM; Abkowitz et al., 1987),
the specific loss of CFU-E implies that this transporter
serves a cellular function uniquely required for CFU-E
differentiation or survival (a conclusion that is further
supported by studies in which normal feline progenitors
infected in vitro with FeLV-C/Sarma have deficient ery-
throid, but preserved myeloid, differentiation [K.M.S.
and J.L.A., unpublished data]).
Here, we demonstrate that FLVCR functions as an
exporter of cytoplasmic heme and provide evidence of
FLVCR’s importance for human erythroid cell differenti-
ation.
Results
FLVCR Expression in Cells and Cell Lines
FLVCR is widely expressed as demonstrated by North-
ern blot analysis (Tailor et al., 1999; Z.Y., J.G.Q., and
J.L.A., unpublished data) and by the broad range of
tissues easily infected by FeLV-C in vivo and in vitro
(Dean et al., 1992 and references therein). Thus, as an
initial study to gain insight into FLVCR function, we
quantitated human FLVCR mRNA and cell surface pro- Figure 1. FLVCR Expression in Human Cells
tein expression in cell lines and primary cells (Figure
Small intestinal (Caco-2) and hepatic phenotype (HepG2) cell lines
1) using RT-PCR and a polyclonal antibody specific to have high levels of FLVCR mRNA (A) and protein (B), as measured by
FLVCR (-FLVCR, Figure 2). These experiments demon- quantitative RT-PCR and flow cytometry with a polyclonal antibody
strate that mRNA and protein expression are particularly specific to FLVCR, -FLVCR, respectively. Studies of cancer cell
lines of breast (MCF7), neuroblastoma (SH-SY5Y), lung (H-460 andhigh in Caco-2 (small intestinal phenotype) and HepG2
A549), cervix (HeLa), rhabdosarcoma (RD-4), and hematologic origin(hepatic phenotype) cells—cell lines previously utilized
are also shown. Mobilized PB CD34 cells and cell lines with anfor studies of heme transport (Galbraith, 1990; Worthing-
early erythroid phenotype (HEL-DR, K562) have high levels of FLVCRton et al., 2001). In addition, as predicted from Unigene
protein on their cell surface, while the more mature erythroid line,
and FLVCR EST expression information (enter FLVCR HEL-R, fails to express FLVCR protein.
as a search term at http://source.stanford.edu), FLVCR
expression is high in a number of cancer cell lines, which
tent of a rat renal epithelial cell line (NRK) engineeredmay have increased heme utilization due to rapid cell
to express the feline ortholog of FLVCR, NRK/feFLVCR,turnover. Notably, mRNA and protein levels are high in
was compared with that of control NRK cells. NRK cellsmobilized peripheral blood (PB) CD34 stem/progenitor
are resistant to FeLV-C infection, implying that the ro-cells and in hematopoietic cell lines with erythroid fea-
dent ortholog of FLVCR is poorly expressed or does nottures (e.g., K562 and HEL-DR), but cell surface protein
efficiently bind FeLV-C; however, once transduced withexpression is absent in a more mature erythroid cell line,
feFLVCR, the cells can be easily infected by FeLV-CHEL-R, with spontaneous hemoglobinization, which is
(Quigley et al., 2000). The heme content of NRK/feFLVCRderived from HEL-DR (Papayannopoulou et al., 1987).
cells was significantly (though minimally) lower than thatIn some cells, there were disparities between protein
of control cells (10.71 vs. 11.93 pmol heme/106 cells,and mRNA expression levels (Figure 1). These dispari-
p  0.04 by two-tailed Student’s t test). We reasonedties may reflect posttranscriptional regulation of protein
that compensatory events during the in vitro selec-levels, for example, regulation of the rate of cycling of
tion and expansion of the cell lines might account forFLVCR protein to and from the cell surface, a control
the smallness of the difference in steady-state hememechanism important in the cell surface expression of
content.another MFS permease, the Glut-4 transporter (Bryant
We then examined the heme content of cell lines uponet al., 2002).
viral interference with FLVCR cell surface expression.
Feline embryonic fibroblasts (FEA) are readily infectedCellular Heme Content Is Dependent on FLVCR
with both FeLV subgroups B and C (FeLV-B and FeLV-C)Cell Surface Expression
and thus express their respective receptors, fePiT-1 andAs an initial screen, to determine if FLVCR could have
a role in heme trafficking or metabolism, the heme con- feFLVCR (Quigley et al., 2000; Rudra-Ganguly et al.,
FLVCR Exports Cytoplasmic Heme
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at baseline  0, after the 30 min load  74.9%  10.5%,
and after 90 min of washout [120 min total time] 
36.5%  5.2%; p  0.001), and thus 51.3%  7.1% of
ZnMP was exported. However, the MFI of control cells
did not change significantly and export was 5.3% 
0.6% (p  NS) (Figure 3B). In addition, there was no
change in the cellular ZnMP content of NRK/FLVCR cells
when washout experiments were performed at 4C,
demonstrating that export is a temperature-dependent
process (Figures 3A and 3B).
The uptake and washout studies were repeated using
55Fe-hemin so that heme export could be directly as-
sessed. These studies required preincubation with
ZnMP to prevent the breakdown of 55Fe-heme by the
cytosolic enzyme HO and thus confirm that both ZnMP
and 55Fe-hemin were internalized. Cells were incubated
with 55Fe-hemin then placed in washout buffer, and the
decrease in the cells’ radioactivity was measured overFigure 2. -FLVCR Is Specific for Human FLVCR
time. As shown in Figure 3C, the results were compara-Western blot analysis demonstrates the specificity of the rabbit
ble to those seen when the export of the mesoporphyrinpolyclonal antibody, -FLVCR. A single band is detected in this
study of HepG2 cell lysates. Its location is in agreement with the was tracked. Forty-nine two percent of 55Fe-heme was
predicted mass of FLVCR. exported by NRK/FLVCR cells (p 0.01), while the heme
content of control NRK/ev cells and NRK/14q cells, cells
engineered to overexpress an FLVCR paralog on chro-
1998). Infection of FEA cells with either retrovirus impairs mosome 14q (Lipovich et al., 2002), did not decrease
the surface expression of its specific cell surface recep- significantly during the washout period.
tor through binding of the viral envelope protein to re- Quantification of heme in the supernatant confirmed
ceptor in the ER or Golgi apparatus. This viral interfer- these findings. Specifically, 107 NRK/FLVCR and NRK/ev
ence prevents further infection of the cell by retroviruses cells were preincubated with ZnMP (to inhibit HO),
of the same subgroup (Weiss and Tailor, 1995). Infection loaded with heme over 30 min, then washed extensively
of FEA cells with FeLV-B (FEA/FeLV-B) has no effect and placed in washout buffer as described above. After
on cell heme content. However, infection with FeLV-C, 90 min, the amount of heme (and mesoporphyrin) exported
which impairs cell surface expression of FLVCR, results into the washout buffer was determined by organic extrac-
in a significant increase in the intracellular heme content tion of heme and porphyrins from the media, and their
of FEA cells (FEA, 5.91 pmol heme/106 cells; FEA/FeLV-B, separation done by high-performance liquid chromatog-
6.30 pmol heme/106 cells; FEA/FeLV-C, 10.96 pmol raphy (HPLC; Lu¨bben and Morand, 1994). NRK/FLVCR
heme/106 cells; p 0.05 FEA/FeLV-C versus FEA/FeLV-B cells exported 3292  424 pmol of heme/107 cells into
cellular heme content). the washout buffer, while NRK/ev cells exported 1762
106 pmol (p  0.004). Consistent with these results,
NRK/FLVCR cells also exported 1504  10 pmol ofHeme Is Exported by FLVCR
ZnMP into the washout buffer, while NRK/ev cells ex-We next evaluated heme transport using zinc meso-
ported 789 25 pmol/107 cells (p 0.001). Thus, despiteporphyrin (ZnMP), a fluorescent heme analog previously
reduced porphyrin loading of NRK/FLVCR cells due tovalidated in heme transport studies (Worthington et al.,
continued export during the loading phase (see Figure2001). NRK cells transduced with human FLVCR (NRK/
3B), there is an approximately 2-fold increase in bothFLVCR) or empty vector alone (NRK/ev) were incubated
the heme and ZnMP content of the washout buffer, dem-in ZnMP for 30 min at 37C, and quantitative fluores-
onstrating that FLVCR exports heme (and ZnMP).cence microscopy was performed. The mean fluores-
Lastly, to demonstrate that FLVCR exports heme fromcent intensity (MFI) of NRK/FLVCR cells was 74.5% 
human hematopoietic cells and is required for erythroid10.9% SD of that of NRK/ev cells (n  5 experiments,
differentiation, we studied its cell surface expres-p  0.001, two-tailed Student’s t test). As ZnMP blocks
sion and function in K562 cells. As shown in Figure 1its own catabolism within cells by inhibition of micro-
and Table 1, FLVCR is highly expressed in undifferenti-somal HO (Worthington et al., 2001), the reduced net
ated K562 cells. Since human FLVCR efficiently bindsintracellular accumulation (or loading) of ZnMP ob-
FeLV-C, these cells can be infected with FeLV-C (K562/served in NRK/FLVCR cells after 30 min must result
FeLV-C). As expected, the cell surface expression offrom either increased export or impaired import of the
FLVCR decreases through viral interference (despite amesoporphyrin.
compensatory increase in FLVCR mRNA levels). ThisTo distinguish between these possibilities, we studied
results in a dramatic reduction in 55Fe-heme export.the washout of ZnMP. Cells were loaded with ZnMP,
K562/FeLV-C cells export only 3% 6% of accumulatedwashed extensively, then placed in buffer alone for 90
55Fe-heme, while naive K562 cells export 54%  8%,min, and the percentage of ZnMP exported was deter-
and cells infected with FeLV-B, which decreases themined by calculating the ratio of the cellular MFI after
cell surface expression of human Pit-1 (Takeuchi et al.,washout to the MFI after loading. The MFI of NRK/FLVCR
cells markedly decreases during the washout period (MFI 1992), export 54%  10%. Notably, there is a similar
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decrease in heme export when the function of FLVCR
is inhibited by incubation with -FLVCR (0.25 mg/ml).
In addition, the inhibition of FLVCR cell surface ex-
pression (by FeLV-C) or FLVCR function (by -FLVCR)
significantly impairs the ability of these cells to undergo
erythroid differentiation, as assessed by the frequency
of benzidine-positive cells present after 3 days of expo-
sure to hemin (50 M) or imatinib (0.25 M; Table 1; or
butyrate [0.5 mM] or TGF- [5 ng/ml]; K.M.S. and J.L.A.,
unpublished data]). As importantly, when FLVCR is in-
hibited and erythroid differentiation is induced, apopto-
sis initiates, as shown by an increase in annexin V bind-
ing (Table 2).
The Expression of FLVCR on the Surface
of CFU-E Is Higher Than on Other
Hematopoietic Progenitor Cells
The specific loss of CFU-E in cats infected with FeLV-C
suggests that the function of FLVCR as a heme exporter
is uniquely important at this stage of erythropoiesis. We
therefore examined the expression of FLVCR on CFU-E
derived from mobilized human PB CD34 stem/progeni-
tor cells. CD34 cells were incubated in stem cell factor
(SCF), interleukin 3 (IL3), and IL6 for 48 hr, and then in
an erythroid differentiation cocktail containing SCF, IL3,
and erythropoietin for 72 hr. Next, cells were sorted by
FACS (using -FLVCR) into two populations, FLVCRhi,
comprising the brightest 13%, and FLVCRlo, the bottom
77%, and the prevalence of erythroid and myeloid pro-
genitors (BFU-E, CFU-E, and CFU-GM) was quantitated
using methylcellulose assays. The FLVCRhi population
contained 48.7%  9.2% of all CFU-E present in the
initial samples, an enrichment of CFU-E content of 3.8-
fold, but as expected, BFU-E and CFU-GM were distrib-
uted proportionally across both subpopulations with av-
erage enrichments of 1.1-fold (n  4 experiments). A
representative study is shown in Figure 4.
FLVCR Cell Surface Expression Decreases
as Erythropoiesis Proceeds
An extension of our hypothesis is that FLVCR expression
might decrease as CFU-E differentiate and hemoglobini-
zation proceeds. To investigate this possibility, the
FLVCR cell surface expression of normal human BMFigure 3. Overexpression of FLVCR Increases Export of the Heme
Analog ZnMP and 55Fe-Heme cells was examined by flow cytometry. Maturing ery-
Cells engineered to overexpress FLVCR (NRK/FLVCR) and control throid forms (CD71hi, CD34neg) had consistently less
cells (NRK/ev) were incubated with ZnMP (5 M) for 30 min at 37C, FLVCR expression than did CD34 cells (1.98  0.87
then washed and incubated for 90 min in buffer alone at 37C or versus 4.71  2.61 relative fluorescent units, p  0.01,
4C. The relative fluorescence of NRK/FLVCR cells is reduced at
n  10).37C (A, right panels). No effects are seen at 4C (A, left panels).
In additional experiments, we observed the FLVCRThe analysis of ZnMP washout after 30 and 90 min (B) demonstrates
a significant time-dependent reduction in NRK/FLVCR cell fluores- protein and mRNA expression of mobilized PB CD34
cence at 37C, but not at 4C (n  4 independent studies). cells undergoing erythroid differentiation during 10 days
Similar studies of NRK/FLVCR and control cells were performed of culture (Figure 5). At day 0, the FLVCR cell surface
with 55Fe-heme. After a brief incubation in ZnMP to inhibit HO activity,
protein expression was high, but by day 10, as hemoglo-55Fe-hemin (0.9 M) was added to the cell media for 30 min. Next,
binized cells predominated in the culture, protein ex-cells were washed and the cellular 55Fe-heme content was quantified.
Cells were then incubated in buffer alone for 90 min to observe 55Fe- pression decreased to background levels. The downreg-
heme washout (n 3). There is a significant decrease in the 55Fe-heme ulation of expression with erythroid maturation is also
content of NRK/FLVCR, but not NRK/ev cells or NRK/14q cells (cells in agreement with the results from studies of the mature
engineered to overexpress a FLVCR paralog on chromosome 14q)
and immature human erythroid cell lines, HEL-R and(C). When the ZnMP pre-incubation step was omitted, 55Fe-heme
HEL-DR (Figure 1).disappeared quickly and equivalently from NRK/FLVCR and control
cells (data not shown).
FLVCR Exports Cytoplasmic Heme
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Table 1. Impairment of FLVCR Expression or Function in K562 Cells Inhibits Heme Export and Erythroid Differentiation
Cell Lines FLVCR Expression Heme Export Ability to Differentiate
Benzidine-Positive After 3
days of Incubation in (%):
mRNA (copies 	 55Fe-Heme
Protein (MFI) 1000/50 ng RNA) Exported (%) a) Hemin b) Imatinib
K562 34.3  10.4 51.4  2.2 54  8 51.2  4.1 60.7  0.9
K562/FeLV-B 26.8  3.2 61.4  11.7 54  10 51.5  2.0 61.8  0.6
K562/FeLV-C 18.4  3.3 88.4  6.2 3  6 20.7  5.5 31.4  0.7
K562  control IgG ND ND 44  4 50.6  5.2 59.5  1.7
K562  -FLVCR ND ND 6  4 28.2  1.2 24.4  1.5
p values
K562/FeLV-C versus p  0.05 p  0.05 p  0.01 p  0.05 p  0.01
K562/FeLV-B
K562/FeLV-C versus K562 p  0.05 p  0.01 p  0.01 p  0.05 p  0.01
K562  -FLVCR versus ND ND p  0.01 p  0.05 p  0.01
K562  control IgG
K562 cells were differentiated utilizing hemin (50 M) or imatinib (0.25 M). Results represent the mean  SD of 4–6 independent studies.
p values were derived with two-tailed Student’s t-tests. As a further control, -FLVCR IgG was incubated with NRK/FLVCR cells (to adsorb the
-FLVCR activity) prior to incubation with K562 cells. Adsorption abrogated the -FLVCR-induced impairment of K562 erythroid differentiation.
Discussion feFLVCR have a significant decrease in cellular heme
content, while specific (FeLV-C) interference with
feFLVCR expression or function significantly increasesNumerous reports, beginning in the 1950s, allude to the
presence of a heme binding protein on the surface of cellular heme content.
In order to directly demonstrate the role of FLVCRmammalian cells (enterocytes, hepatocytes, and hema-
topoietic cell lines) (Galbraith, 1990; Worthington et al., in heme export, we performed quantitative fluorescent
microscopy studies on cell lines overexpressing human2001; reviewed in Uzel and Conrad, 1998). However,
these putative mammalian heme importers were not FLVCR, utilizing a fluorescent heme analog, zinc meso-
porphyrin (ZnMP). ZnMP has been used to examineidentified. Here, we have performed a series of experi-
ments which indicate that the human ortholog of heme transport in intestinal and hepatic cell lines (Wor-
thington et al., 2001) and yeast (M.T.W., unpublishedfeFLVCR, FLVCR, exports cytoplasmic heme and is im-
portant for erythroid differentiation. data). Due to its potent inhibition of HO, changes in
cellular fluorescence reflect mesoporphyrin trafficking
and not modification of heme or ZnMP catabolism (Wor-Identification of FLVCR as a Mammalian
Heme Exporter thington et al., 2001). Our studies demonstrate a sig-
nificant reduction in ZnMP accumulation in cells over-FLVCR mRNA and protein expression levels are in-
creased in cell lines derived from tissues that either expressing FLVCR as compared to control cells under
steady-state conditions. More importantly, washouttransport heme (e.g., intestinal and hepatic cell lines) or
have increased heme synthesis (e.g., erythroid cell studies show a dramatic time-dependent decrease in
the fluorescence of NRK/FLVCR but not control cellslines). In addition, cell lines engineered to overexpress
Table 2. Impairment of FLVCR Expression or Function in K562 Cells Is Associated with Apoptosis
Cell Lines Induction by Hemin Induction by Imatinib
Annexin V Annexin V
Binding (%) PI Positive (%) Binding (%) PI Positive (%)
K562 9.6  0.1 0.01  0.01 12.9  0.4 0.04  0.05
K562/FeLV-B 8.7  1.2 0.01  0.01 11.3  0.5 0.02  0.03
K562/FeLV-C 23.6  0.8 0.02  0.02 21.4  3.8 0.32  0.14
K562  control IgG 10.6  1.3 0.02  0.01 10.9  0.4 0.01  0.01
K562  -FLVCR 25.3  0.6 0.02  0.02 21.9  0.9 0.02  0.01
p values
K562/FeLV-C versus p  0.005 p  NS p  0.07 p  NS
K562/FeLV-B
K562/FeLV-C versus K562 p  0.002 p  NS p  0.09 p  NS
K562  -FLVCR versus K562  p  0.005 p  NS p  0.03 p  NS
control IgG
K562 cells were differentiated utilizing hemin (50 M) or imatinib (0.25 M) for 24 hr. Early and late apoptosis was assessed by binding of
annexin V and staining with propidium iodide (PI), respectively. Results represent the mean  SD of two independent studies. p values were
derived with two-tailed Student’s t-tests.
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Figure 4. FLVCR Expression Is High on
CFU-E Progenitor Cells
Mobilized PB CD34 cells were exposed to
an erythroid differentiation cocktail for 72 hr.
FLVCR cells were then sorted into FLVCRhi
(13% with highest fluorescence) and FLVCRlo
(bottom 77%) subpopulations. The number
of progenitors derived from sorting 106 cells
is shown. In this representative study, the
FLVCRhi population contains 54% of all
FLVCR CFU-E, when 13% is expected, a
4.2-fold enrichment, while the early erythroid
progenitors, BFU-E, and granulocyte-macro-
phage progenitors, CFU-GM, are distributed
normally. Similar results were observed in
three independent experiments.
indicating that FLVCR exports heme. Similar fluores- binding permease that delivers heme to the cytoplasm
have been described in gram-negative bacteria (seecence methodologies and experimental design have
been utilized to demonstrate the role of other secondary Wandersman and Stojiljkovic, 2000 for review). Detailed
analysis of the hemoreceptors has revealed a conservedtransporters (e.g., Bmr, Neyfakh et al., 1991 and QacA,
Mitchell et al., 1999) in multidrug export from bacteria. receptor domain containing invariant histidine residues,
FRAP and NPNL amino acid boxes, suggesting theirIn confirmatory studies, the 55Fe-heme content of
NRK/FLVCR cells and NRK/ev cells was quantified after importance in prokaryotic heme binding and/or trans-
port. In addition, a number of mammalian intracellular55Fe-hemin exposure and washout conditions—studies
performed in the presence of ZnMP to competitively heme binding proteins (e.g., HBP23; Iwahara et al., 1995)
and more general tetrapyrrole binding proteins (e.g.,inhibit HO-mediated catabolism of 55Fe-heme. Identical
experiments with NRK cells overexpressing a paralog of p22HBP; Jacob Blackmon et al., 2002; Taketani et al.,
1998) have been identified. Sequence comparisons,FLVCR from chromosome 14q (60% amino acid identity;
Lipovich et al., 2002) demonstrate that heme export is however, show no similarity between FLVCR and these
proteins or HemR.a specific function of FLVCR (Figure 3C). Furthermore,
quantification of porphyrins in the washout supernatants
of NRK/FLVCR cells (with HPLC) proves that heme (and Heme Export Is of Critical Importance
in ErythropoiesisZnMP) are exported as intact molecules across the cell
surface membrane. Heme is essential to oxidation-reduction reactions in
all aerobic cells, thus it is not surprising that FLVCRFinally, 55Fe-heme washout studies in K562 cells, a
human erythroid cell line, demonstrate that specific in- orthologs are present in bacterial, plant, and animal ge-
nomes (Lipovich et al., 2002; see also http://www.ncbi.terference with either the cell surface expression of
FLVCR (by FeLV-C) or its membrane transport function nlm.nih.gov/sutils/blink.cgi?pid7661708). However, in
mammals, heme has a unique role in oxygen binding(by -FLVCR) significantly reduces the export of heme.
As heme can stick indiscriminately to phospholipid-con- and transport as the prosthetic group of hemoglobin in
erythrocytes. At, or just after, the CFU-E stage of ery-taining cell membranes, experiments where FLVCR is
selectively modulated are critical. The -FLVCR experi- throid differentiation, heme synthesis increases, as doc-
umented by 59Fe incorporation into heme (Wickrema etments are especially informative as they demonstrate
that targeted (and nonretroviral-mediated) cell surface al., 1992). We propose that this results in a unique re-
quirement for FLVCR to control intracellular heme con-inhibition of FLVCR function impairs heme export.
We have no evidence to suggest that FLVCR is a tent. In agreement with this hypothesis, these progeni-
tors have increased levels of FLVCR on their cell surfacebidirectional heme transporter. The observations dem-
onstrating increased accumulation of ZnMP in NRK/ev compared to levels on the less-mature progenitor,
BFU-E (Figure 4). Also, a region of the FLVCR promoter,compared with NRK/FLVCR cells after a 30 min loading
phase speak against an import function (Figures 3A and between 
370 and 
1030 nucleotides relative to the
translation initiation site, contains four potential STAT5a3B). Also, studies following the overnight incubation of
these cells with the heme synthesis inhibitor succinylac- binding sites, as well as consensus GATA-1, GATA-2,
c-myb and NF-E2 binding sites, providing potentialetone (Ponka et al., 1982; Worthington et al., 2001) sug-
gest that FLVCR does not reverse function even when mechanisms for the upregulation of FLVCR transcription
during early erythroid commitment and differentiation.intracellular heme is depleted (M.T.W., unpublished
data). An extension of our hypothesis is that FLVCR expres-
sion may be downregulated when globin protein levelsProkaryotic heme import systems consisting of an
outer membrane TonB-dependent hemoreceptor (e.g., increase and hemoglobinization proceeds. The analyses
of the erythroid cell lines HEL-DR and HEL-R, data fromHemR), a periplasmic heme binding protein, and an ATP
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Figure 5. FLVCR mRNA and Cell Surface Protein Expression Decrease as CD34 Cells Differentiate
FLVCR mRNA and protein expression were observed during 10 days of erythroid differentiation. The number of CD34 cells decreases (A),
CD71 cells increase (not shown), and hemoglobinization occurs (as measured by benzidine staining [B]) during this time. Initially there are
high frequencies of CFU-GM (not shown) and BFU-E (C) but few CFU-E. The number of CFU-E increases throughout the study; however, their
frequency remains constant due to an increase in the number of maturing erythroid cells (D). The FLVCR expression in this heterogeneous
population of cells is initially high but decreases with erythroid differentiation (E–F). The results reflect the mean (SD) of three independent
experiments plus two additional studies observing days 0–3.
normal BM CD34 versus maturing (bright CD71) ery- K562 cells and improves the differentiation of erythroid
progenitors (BFU-E) in vitro (Holden et al., 1983; Ruther-throid cells, and the studies of FLVCR mRNA and protein
expression during the in vitro differentiation of mobilized ford et al., 1979). Heme upregulates the erythroid heme
human peripheral blood CD34 cells (and K562 cells; biosynthetic pathway, possibly through inhibition of the
Z.Y. and J.L.A., unpublished data) all support this transcriptional repressor, Bach1, and also contributes
premise. to optimal transferrin receptor expression (Ponka, 1997).
The studies of K562 cells are also in accordance with Furthermore, erythroid differentiation is arrested upon
the concept that FLVCR is required for erythroid differ- disruption of the murine erythroid-specific 5-aminolevu-
entiation. Retroviral interference with FLVCR expression linate synthase gene (ALAS-2), the critical initial enzyme
or specific antibody-mediated inhibition of FLVCR func- in erythroid intracellular heme synthesis (Nakajima et
tion impairs both heme export and the subsequent he- al., 1999). Thus, the results presented here, demon-
moglobinization of these cells (Table 1). Also, there is strating that FLVCR-mediated heme export is required
increased apoptosis (Table 2). It is possible that heme during early erythroid development, may appear coun-
excess (e.g., through oxidative cell membrane damage) terintuitive. Heme, however, is also toxic, necessitating
induces apoptosis and, in turn, the failure of erythroid redundant mechanisms to stringently control its intracellu-
differentiation. Alternatively, heme excess might dysreg- lar concentration. Thus, we hypothesize that FLVCR func-
ulate erythropoiesis (e.g., by prematurely initiating glo- tions as a cell membrane export channel (overflow
bin translation) and cause apoptosis. valve), providing a safety mechanism that is uniquely
The effects of FeLV-C viremia on feline erythropoiesis, important at the CFU-E stage of differentiation.
where there is normal development of BFU-E but severe Regulation of intracellular heme levels differs mark-
anemia due to a block of CFU-E and further erythroid edly between erythroid and nonerythroid cells. In hepa-
maturation, attest to the importance of FLVCR function tocytes, for example, the heme pool is regulated through
in vivo. As the viral envelope interferes with the expres- a combination of synthetic and degradative mecha-
sion/function of its receptor (FLVCR) in all infected cells nisms (through heme-mediated negative feedback con-
(including BFU-E and CFU-GM progenitors; Abkowitz trol of ALAS-1 and heme induction of HO). In contrast,
et al., 1987), the specific loss of cells at the CFU-E stage in erythroid cells, the erythroid-specific isozyme ALAS-2
of differentiation argues for a unique requirement for is not regulated by heme, but rather by iron supply (re-
heme export at this time. viewed in Ponka, 1997). In addition, there is no evidence
that HO is induced by endogenous heme; studies of the
murine erythroid cell line MEL have shown that differenti-FLVCR Functions as an Overflow Valve
ation is in fact associated with a reduction in HO mRNAPrevious studies demonstrate that exogenous heme in-
duces the erythroid differentiation of cell lines such as levels (Fujita and Sassa, 1989). Thus, apart from the
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Heme Content of NRK Cell Linesability to upregulate globin protein synthesis, there is a
Heme content (reported as pmol heme/106 cells) was determinedpaucity of identified heme control mechanisms in ery-
as described previously (Sassa, 1976).throid cells, presumably related to their requirement for
maximal heme synthesis. We conclude that expression ZnMP Uptake and Washout Studies
of a heme exporter on the cell membrane is therefore NRK/FLVCR and NRK/ev cell lines were grown on chamber slides
required during early erythropoiesis to allow for a rapid in standard media, with parallel 30 min uptake studies performed
at 37C using 5M ZnMP (Frontier Scientific, Logan, Utah) dissolvedcellular response to fluctuating cytosolic heme levels,
in cell culture-grade DMSO to a concentration of 4 mM, followedthus complementing the more static role of induction of
by dilution in washout buffer (25 mM HEPES, [pH 7.4], 130 mM NaCl,globin in preventing heme toxicity.
10 mM KCl, 1 mM CaCl2, 1 mM MgSO4) and 2.5M BSA as previouslyAlthough FLVCR is downregulated with terminal ery- described (Worthington et al., 2001). For washout experiments, the
throid differentiation, we suspect that FLVCR does not cells were washed 3 times and then incubated in working buffer
significantly interfere with heme binding to globin. Over- and 5% BSA at 37C or 4C for 90 min.
expression of FLVCR in K562 cells via retroviral gene
Microscopytransfer does not impede erythroid differentiation (Z.Y.,
Fluorescence microscopic imaging and quantitative digital micros-J.G.Q., and J.L.A., unpublished data). These observa-
copy measurement of cellular ZnMP uptake were performed astions are consistent with a safety mechanism or overflow
described (Worthington et al., 2001). All measurements utilized tripli-
valve hypothesis. cate images for each data point. Digital images were analyzed as
described previously (Worthington et al., 2001). The MFI of cellular
ZnMP in the control NRK/ev cells after 30 min was considered 100%
The Function of FLVCR in Other Tissues in each study.
FLVCR is highly expressed in cell lines with a small
55Fe-Hemin Uptake and Washout Studiesintestinal or hepatic phenotype (Figure 1). As two-thirds
The procedures and buffers were the same as for the ZnMP studies.of body iron derives from dietary heme iron (Carpenter
After a brief rinse with working buffer, the cells (105 cells/well in 12-and Mahoney, 1992), there must be significant heme
well dishes) were incubated with 5 M of ZnMP in washout buffer
trafficking into the small intestine. The liver has the sec- and 2.5 M BSA for 15 min, and then 55Fe-hemin (RI Consultants
ond highest rate of heme biosynthesis (for cytochrome LLC, Hudson, New Hampshire) was added (to a final concentration
P450) and serves as a destination for heme linked to of 0.9 M) for 30 additional minutes. The cells were then washed
three times, and placed in washout conditions (washout buffer andhemopexin or albumin. Thus, FLVCR might facilitate
5% BSA) for 90 min at 37C. To measure cellular radioactivity, theheme transport or, more likely, complement the role of
cells were rinsed twice with washout buffer, detached from theHO induction in the control of cellular heme content at
plates, mixed with liquid scintillation cocktail (ICN), and placed in a
these sites. FLVCR is also expressed in hematopoietic liquid scintillation counter. Counts were normalized by total cell
stem cells (Z.Y. and J.L.A., unpublished data; and see protein content. The maximum scintillation count of control NRK/
Figures 1 and 5), which presumably require stringent ev cells after the 30 min uptake of 55Fe-heme was considered 100%
in each study.protection from heme toxicity to assure genetic integrity.
Although these cells are relatively quiescent, heme syn-
Measurement of Heme and ZnMP Exportthesis is needed for oxidative metabolism. FLVCR may
The procedures and buffers were the same as described for thefunction in their protection from perturbations in endog-
ZnMP and 55Fe-hemin uptake and washout studies, except that cell
enous heme levels or from extracellular heme in the number was increased to 107 cells in T-75 flasks. After preincubation
BM microenvironment (e.g., hemolysis in the BM is a with 5 M ZnMP in working buffer, hemin was added to a final
concentration of 50 M for 30 min (loading). The cells were thenconsequence of ineffective erythropoiesis). Notably, re-
washed and placed in washout conditions as above. After 90 min,cent studies demonstrate that the ABC transporter,
the washout supernatant (30 ml) was collected and kept at 
80CABCG2, which protects stem cells from environmental
until analysis. The extraction of porphyrins was adapted from pre-xenobiotics (Abbott, 2003), also functions as a cell mem-
viously described methods (Smith, 1975). Ten milliliter fractions were
brane export pump for protoporphyrin IX, the direct pre- extracted in parallel three times with 10 ml of ethyl acetate/acetic
cursor of heme in the heme synthesis pathway (Jonker acid 2:1, then washed twice with 0.5 volumes of saturated sodium
acetate. The sodium acetate washings were also extracted withet al., 2002; Krishnamurthy et al., 2004). These data lend
fresh ethyl acetate and combined with the original extract, whichfurther support for the concept that stem cells require
was then washed once with 0.1 volumes of 3% sodium acetate andredundant mechanisms for regulation of heme content.
dried down with argon. Samples were dissolved in buffer and the
heme and mesoporphyrin separated by HPLC, as described (Lu¨bben
and Morand, 1994). Standards of heme, porphyrins and ZnMP (Fron-Experimental Procedures
tier Scientific) were used for peak identification and quantification.
Cell Lines
Western Blot AnalysisHEL-DR and HEL-R cells were a gift from T. Papayannopoulou, MCF7
Western blots of HepG2 lysates were probed with rabbit anti-FLVCRcells were obtained from M.-C. King, RD-4 was a gift of M. Hentze, and
(1 g/ml), or preimmune serum (data not shown), followed by aall other cell lines were obtained from the American Type Culture
1:2000 dilution of HRP-labeled goat anti-rabbit IgG (PharMingen).Collection. NRK/FLVCR and NRK/ev cells were generated by trans-
Detection used a chemiluminescence kit (Supersignal West Picoduction of NRK-52E cells with the retroviral vector MSCVneo (BD
Chemiluminescent kit, Pierce).Biosciences Clontech) containing the human FLVCR cDNA (ampli-
fied from a human kidney cDNA library [BD Biosciences Clontech],
using primers specific to the human FLVCR cDNA [GenBank acces- RNA Isolation, Quantitative RT-PCR, and Northern
Blot Analysission number: AF118637]) or no additional cDNA, respectively. Cells
were selected in G418. The generation of NRK/feFLVCR has been Cells were pelleted, and total RNA isolated using Trizol (Invitrogen),
as suggested by the manufacturer. Total RNA was reverse tran-described previously (Quigley et al., 2000). The cDNA encoding
FLVCRL14q (I.M.A.G.E. clone 4866427) was inserted into MSCVneo, scribed using the SuperScript first-strand synthesis system (In-
vitrogen). Quantitative RT-PCR was performed using TaqMan chem-and NRK/14q cells generated in a similar fashion.
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istry and the ABI PRISM 7700 sequence detection system (Applied Sorting of Mobilized Human PB CD34 Cells
For sorting experiments, cells were thawed and differentiated asBiosystems). The results are expressed as copies 	 1000/50 ng
above. At day 3, cells were pelleted and resuspended at 5 	total RNA. GADPH and 2-microglobulin were used for the internal
106/ml in X-VIVO15 containing 1% BSA, and blocked with 1% donkeynormalization of CD34 cell differentiation and cell line experiments,
serum, then labeled either with -FLVCR or with rabbit IgG, followedrespectively. PCR primers and probes (available on request) were
by R-PE-conjugated donkey anti-rabbit IgG. Cells were washed be-designed using the Primer Express program (Applied Biosystems)
tween incubations with X-VIVO15 and 1% BSA. Labeled cells wereand synthesized at Integrated DNA Technologies, Inc. (Coralville,
resuspended at 5 	 106/ml in X-VIVO15 and 1% BSA and sortedIowa). All forward and reverse primer pairs span an intron. To confirm
using FACSVantage SE (BD Biosciences). From a dot plot of liveour RT-PCR results, Northern blot analyses were performed ac-
cells, the highest expressing 13% were sorted as FLVCRhi and acording to standard protocols, using a 360 bp midsection fragment
distinct population as FLVCRlo. The sorted subpopulations wereof human FLVCR cDNA that does not crossreact with FLVCR para-
then assayed for the prevalence of BFU-E, CFU-E, and CFU-GMlogs in the human genome (Lipovich et al., 2002; Z.Y., J.G.Q., and
progenitors using the methylcellulose culture assay describedJ.L.A., unpublished data).
above.
Generation and Characterization of -FLVCR Flow Cytometric Analysis of Normal Human
Polyclonal rabbit antisera were raised against NRK/FLVCR cell sur- Bone Marrow Cells
face membranes isolated as described (Kinne-Saffran and Kinne, BM was aspirated from ten volunteers, after informed consent, in
1989) (performed at R&R Rabbitry, Stanwood, Washington). Prepa- accordance with institutional guidelines. Cells were labeled with
ration of acetone precipitates of NRK/ev cells was performed as anti-CD71 FITC (clone YDJ1.2.2, Beckman Coulter), anti-CD34 PE-
previously described (Harlow and Lane, 1988). To remove antibodies Cy5 (Beckman Coulter, clone 581), either polyclonal rabbit IgG or
to normal rat proteins, 1 ml of anti-FLVCR rabbit serum was incu- -FLVCR, and an R-PE-conjugated anti-rabbit IgG as a secondary
bated with 20 mg of NRK/ev cell acetone precipitate overnight at antibody prior to flow cytometric analysis using a Coulter-XL (Beck-
4C, centrifuged, and the supernatant applied to a protein A car- man Coulter). CD34 cells were identified by high CD34 expression
tridge connected to a desalting cartridge (protein A antibody purifi- and low sidescatter while maturing erythroid forms were identified
cation kit, Sigma) to purify the anti-FLVCR rabbit IgG, termed by high CD71 expression without CD34 expression. For these stud-
-FLVCR. ies, FLVCR expression was defined as the ratio of the mean fluores-
cence of cells labeled with FLVCR to the mean fluorescence of cells
labeled with the IgG control.
Quantification of Cell Surface Expression of FLVCR
Cells (4	 105) were suspended in 0.5 ml of X-VIVO15 media (Biowhit- Acknowledgments
taker), blocked by 1% donkey serum and 1% BSA, and labeled with
-FLVCR (20 g/ml) followed by R-phycoerythrin (PE)-conjugated We thank R.T. Doty and H.A. Dailey for critical reading of the manu-
donkey anti-rabbit IgG (5 g/ml, Jackson ImmunoResearch Labora- script. This work was supported by grants from the NIH to J.L.A.
tories). The cells were washed with X-VIVO15 between incubations, (HL31823), S.S. (DK32890), and J.D.P. (DK20503) and the Center for
fixed, and kept at 4C until analysis. MFI unit measurements were Clinical Research at the University of Washington (RR00037).
calculated by subtraction of the fluorescence of cells labeled con-
currently with preimmune rabbit IgG. The mean fluorescence of Received: March 2, 2004
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